Thromboembolic events in cancer patients on active treatment with cisplatin-based chemotherapy: another look!

BACKGROUND: The risk of thromboembolic events is higher among cancer patients, especially in patients undergoing chemotherapy. Cisplatin-based regimens claim to be associated with a very high thromboembolic rate. In this study, we report on our own experience with thrombosis among patients on active...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-Razeq, Hikmat, Mansour, Asem, Abdulelah, Hazem, Al-Shwayat, Anas, Makoseh, Mohammad, Ibrahim, Mohammad, Abunasser, Mahmoud, Rimawi, Dalia, Al-Rabaiah, Abeer, Alfar, Rozan, Abufara, Alaa’, Ibrahim, Alaa, Bawaliz, Anas, Ismael, Yousef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831696/
https://www.ncbi.nlm.nih.gov/pubmed/29507532
http://dx.doi.org/10.1186/s12959-018-0161-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831696/
https://www.ncbi.nlm.nih.gov/pubmed/29507532
http://dx.doi.org/10.1186/s12959-018-0161-9

Ejemplares similares